Peter KaoSummaryAffiliation: Stanford University Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case seriesKala K Davis
Division of Pulmonary and Critical Care Medicine, Stanford University Medical Center, Stanford, CA, USA
BMC Pulm Med 7:2. 2007..This study was undertaken to assess the safety, tolerability and preliminary clinical benefits of the addition of aerosolized amikacin to a standard macrolide-based oral treatment regimen...
Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. fDaoming Qiu
Division of Pulmonary and Critical Care Medicine, Stanford University Medical Center, Stanford, California 94305, USA
Drugs R D 4:1-18. 2003..Further characterisation of the molecular mechanisms of triptolide action will serve to elucidate pathways of immune system regulation...- Simvastatin treatment of pulmonary hypertension: an observational case seriesPeter N Kao
Pulmonary and Critical Care Medicine, Stanford University Medical Center, Stanford, CA 94305 5236, USA
Chest 127:1446-52. 2005..In pneumonectomized rats injected with monocrotaline, simvastatin reversed established pulmonary hypertension and conferred a 100% survival advantage... - Dynamic binding of Ku80, Ku70 and NF90 to the IL-2 promoter in vivo in activated T-cellsLingfang Shi
Pulmonary and Critical Care Medicine, Stanford University Medical Center, Stanford, CA 94305 5236, USA
Nucleic Acids Res 35:2302-10. 2007..Dynamic changes in binding of Ku80, Ku70 and NF90 to the IL-2 proximal promoter in vivo correlate with chromatin remodeling and transcriptional initiation in activated T-cells... - Longitudinal transcriptional analysis of developing neointimal vascular occlusion and pulmonary hypertension in ratsLaszlo T Vaszar
Division of Pulmonary/Critical Care Medicine, Stanford University Medical Center, Stanford, California 94305-5236, USA
Physiol Genomics 17:150-6. 2004..Mast-cell-derived proteases may play a role in regulating the development of neointimal pulmonary vascular occlusion and pulmonary hypertension in response to injury... - Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cellsToshihiko Nishimura
Division of Pulmonary and Critical Care Medicine, Stanford University Medical Center, Stanford, Calif 94305-5236, USA
Circulation 108:1640-5. 2003..CONCLUSIONS: Simvastatin reverses pulmonary arterial neointimal formation and PAH after toxic injury... - Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in ratsToshihiko Nishimura
Division of Pulmonary and Critical Care Medicine, and Department of Pathology, Stanford University Medical Center, Stanford, California 94305, USA
Am J Respir Crit Care Med 166:1403-8. 2002..Simvastatin attenuates monocrotaline-induced pulmonary vascular remodeling with neointimal formation, pulmonary arterial hypertension, and right ventricular hypertrophy in rats... - Simvastatin enhances bone morphogenetic protein receptor type II expressionHong Hu
Division of Pulmonary and Critical Care Medicine, Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305-5236, USA
Biochem Biophys Res Commun 339:59-64. 2006..Simvastatin induction of BMPR2 expression may improve BMP-BMPR2 signaling thereby enhancing endothelial differentiation and function... - Effect of a surgical aortocaval fistula on monocrotaline-induced pulmonary hypertensionToshihiko Nishimura
Division of Pulmonary and Critical Care Medicine, Stanford University Medical Center, 300 Pasteur Avenue, Stanford, CA 94305, USA
Crit Care Med 31:1213-8. 2003..034). CONCLUSIONS: The presence of a surgical aortocaval fistula attenuates, rather than worsens, the development of monocrotaline-induced pulmonary hypertension in rats... - High prevalence of autoimmune thyroid disease in pulmonary arterial hypertensionJames W Chu
Divisions of Endocrinology and Metabolism, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305-5236, USA
Chest 122:1668-73. 2002..Systematic surveillance for occult thyroid dysfunction in patients with PAH may prevent the hemodynamic exacerbation of right heart failure... - Emerging therapies for pulmonary hypertension: striving for efficacy and safetyPeter N Kao
J Am Coll Cardiol 41:2126-9. 2003 - Pulmonary arterial hypertension: future directions: report of a National Heart, Lung and Blood Institute/Office of Rare Diseases workshopJohn H Newman
Departments of Medicine, Nashville VA Medical Center (GRECC, and Vanderbilt University, Nashville, Tenn, USA
Circulation 109:2947-52. 2004
Research Grants
- T-Cells in Lung InflammationPeter N Kao; Fiscal Year: 2010..Further molecular insights into the regulation of IL-2 gene expression in activated T-cells will identify novel targets and strategies for therapeutic manipulation of T-cell immune responses in disease. ..
- T-Cells in Lung InflammationPeter Kao; Fiscal Year: 2007..Further molecular insights into the regulation of IL-2 gene expression in activated T-cells will identify novel targets and strategies for therapeutic manipulation of T-cell immune responses in disease. ..
- T-Cells in Lung InflammationPeter Kao; Fiscal Year: 2005..Increased understanding of T-cell activation and its modulation by immunosuppressant drugs will guide future therapies for lung inflammation, autoimmune diseases, cancer and AIDS. ..
- EPITHELIAL CELLS IN LUNG INFLAMMATIONPeter Kao; Fiscal Year: 2003..A signaling enzyme in HBE cells which is specifically inactivated by PG490 and which regulates NF-kappaB transcriptional activation in the nucleus will be isolated and characterized. ..
- T CELLS IN LUNG INFLAMMATIONPeter Kao; Fiscal Year: 2000..Understanding T-cell cytokine expression and its modulation by immunosuppressant drugs and viral transactivating proteins will guide future therapies of lung inflammation. ..